Multiscale reverse engineering of the human ocular surface.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
08 2019
Historique:
received: 31 01 2018
accepted: 21 06 2019
pubmed: 7 8 2019
medline: 7 11 2019
entrez: 7 8 2019
Statut: ppublish

Résumé

Here we present a miniaturized analog of a blinking human eye to reverse engineer the complexity of the interface between the ocular system and the external environment. Our model comprises human cells and provides unique capabilities to replicate multiscale structural organization, biological phenotypes and dynamically regulated environmental homeostasis of the human ocular surface. Using this biomimetic system, we discovered new biological effects of blink-induced mechanical forces. Furthermore, we developed a specialized in vitro model of evaporative dry-eye disease for high-content drug screening. This work advances our ability to emulate how human physiological systems interface with the external world, and may contribute to the future development of novel screening platforms for biopharmaceutical and environmental applications.

Identifiants

pubmed: 31384041
doi: 10.1038/s41591-019-0531-2
pii: 10.1038/s41591-019-0531-2
pmc: PMC6950645
mid: NIHMS1062057
doi:

Substances chimiques

Glycoproteins 0
lubricin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1310-1318

Subventions

Organisme : NHLBI NIH HHS
ID : DP2 HL127720
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY025742
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES013508
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026972
Pays : United States

Références

Proksch, E., Brandner, J. M. & Jensen, J.-M. The skin: an indispensable barrier. Exp. Dermatol. 17, 1063–1072 (2008).
doi: 10.1111/j.1600-0625.2008.00786.x
Wanner, A., Salathé, M. & O’Riordan, T. G. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med. 154, 1868–1902 (1996).
doi: 10.1164/ajrccm.154.6.8970383
Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799 (2009).
doi: 10.1038/nri2653
Marchiando, A. M., Graham, W. V. & Turner, J. R. Epithelial barriers in homeostasis and disease. Annu. Rev. Pathol. 5, 119–144 (2010).
doi: 10.1146/annurev.pathol.4.110807.092135
Gipson, I. K. The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 48, 4391–4398 (2007).
doi: 10.1167/iovs.07-0770
Ehlers, N. et al. Morphological evaluation of normal human corneal epithelium. Acta Ophthalmol. 88, 858–861 (2010).
doi: 10.1111/j.1755-3768.2009.01610.x
Pfister, R. R. & Burstein, N. L. The normal and abnormal human corneal epithelial surface: a scanning electron microscope study. Invest. Ophthalmol. Vis. Sci. 16, 614–622 (1977).
pubmed: 873722
Nichols, B., Dawson, C. R. & Togni, B. Surface features of the conjunctiva and cornea. Invest. Ophthalmol. Vis. Sci. 24, 570–576 (1983).
pubmed: 6841003
Gipson, I. K. Distribution of mucins at the ocular surface. Exp. Eye Res. 78, 379–388 (2004).
doi: 10.1016/S0014-4835(03)00204-5
Bron, A. J. et al. TFOS DEWS II pathophysiology report. Ocul. Surf. 15, 438–510 (2017).
doi: 10.1016/j.jtos.2017.05.011
Meloni, M., De Servi, B., Marasco, D. & Del Prete, S. Molecular mechanism of ocular surface damage: application to an in vitro dry eye model on human corneal epithelium. Mol. Vis. 17, 113–126 (2011).
pubmed: 21245952 pmcid: 3021568
Lu, Q., Yin, H., Grant, M. P. & Elisseeff, J. H. An in vitro model for the ocular surface and tear film system. Sci. Rep. 7, 6163–6163 (2017).
doi: 10.1038/s41598-017-06369-8
Kwon, K. A. et al. High-speed camera characterization of voluntary eye blinking kinematics. J. R. Soc. Interface 10, 20130227 (2013).
doi: 10.1098/rsif.2013.0227
Farris, R. L., Stuchell, R. N. & Mandel, I. D. Basal and reflex human tear analysis: I. Physical measurements: osmolarity, basal volumes, and reflex flow rate. Ophthalmology 88, 852–857 (1981).
doi: 10.1016/S0161-6420(81)34939-2
Doane, M. G. Interaction of eyelids and tears in corneal wetting and the dynamics of the normal human eyeblink. Am. J. Ophthalmol. 89, 507–516 (1980).
doi: 10.1016/0002-9394(80)90058-6
Jones, M. B., Fulford, G. R., Please, C. P., McElwain, D. L. S. & Collins, M. J. Elastohydrodynamics of the eyelid wiper. Bull. Math. Biol. 70, 323–343 (2008).
doi: 10.1007/s11538-007-9252-7
Masterton, S. & Ahearne, M. Mechanobiology of the corneal epithelium. Exp. Eye Res. 177, 122–129 (2018).
doi: 10.1016/j.exer.2018.08.001
Sakai, E., Shiraishi, A., Yamaguchi, M., Ohta, K. & Ohashi, Y. Blepharo-tensiometer: new eyelid pressure measurement system using tactile pressure sensor. Eye Contact Lens 38, 326–330 (2012).
doi: 10.1097/ICL.0b013e318268610a
Yamamoto, Y. et al. Involvement of eyelid pressure in lid-wiper epitheliopathy. Curr. Eye Res. 41, 171–178 (2016).
doi: 10.3109/02713683.2015.1009636
Shaw, A. J., Collins, M. J., Davis, B. A. & Carney, L. G. Eyelid pressure and contact with the ocular surface. Invest. Ophthalmol. Vis. Sci. 51, 1911–1917 (2010).
doi: 10.1167/iovs.09-4090
Shaw, A. J. B. Eyelid Pressure on the Cornea. PhD thesis (Queensland Univ. of Technology; 2009).
Molladavoodi, S., Robichaud, M., Wulff, D. & Gorbet, M. Corneal epithelial cells exposed to shear stress show altered cytoskeleton and migratory behaviour. PloS ONE 12, e0178981 (2017).
Ren, H. & Wilson, G. The effect of a shear force on the cell shedding rate of the corneal epithelium. Acta Ophthalmol. Scand. 75, 383–387 (1997).
doi: 10.1111/j.1600-0420.1997.tb00394.x
Nowell, C. S. & Radtke, F. Corneal epithelial stem cells and their niche at a glance. J. Cell Sci. 130, 1021–1025 (2017).
pubmed: 28202689
Tsubota, K. Tear dynamics and dry eye. Prog. Retin. Eye Res. 17, 565–596 (1998).
doi: 10.1016/S1350-9462(98)00004-4
Willcox, M. D. P. et al. TFOS DEWS II tear film report. Ocul. Surf. 15, 366–403 (2017).
doi: 10.1016/j.jtos.2017.03.006
Bunya, V. Y. et al. Variability of tear osmolarity in patients with dry eye. JAMA Ophthalmol. 133, 662–667 (2015).
doi: 10.1001/jamaophthalmol.2015.0429
Stevenson, W., Chauhan, S. K. & Dana, R. Dry eye disease: an immune-mediated ocular surface disorder. Arch. Ophthalmol. 130, 90–100 (2012).
doi: 10.1001/archophthalmol.2011.364
Rhee, M. K. & Mah, F. S. Inflammation in dry eye disease: how do we break the cycle? Ophthalmology 124, S14–S19 (2017).
doi: 10.1016/j.ophtha.2017.08.029
Schlote, T., Kadner, G. & Freudenthaler, N. Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use. Graefe’s Arch. Clin. Exp. Ophthalmol. 242, 306–312 (2004).
doi: 10.1007/s00417-003-0845-z
Abdelfattah, N. S., Dastiridou, A., Sadda, S. R. & Lee, O. L. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea 34, S48–S52 (2015).
doi: 10.1097/ICO.0000000000000570
Tian, L., Qu, J. H., Zhang, X. Y. & Sun, X. G. Repeatability and reproducibility of noninvasive keratograph 5M measurements in patients with dry eye disease. Am. J. Ophthalmol. 2016, 8013621 (2016).
Koh, S. et al. Regional differences in tear film stability and meibomian glands in patients with aqueous-deficient dry eye. Eye Contact Lens 42, 250–255 (2016).
doi: 10.1097/ICL.0000000000000191
Bron, A. J., Argueso, P., Irkec, M. & Bright, F. V. Clinical staining of the ocular surface: mechanisms and interpretations. Prog. Retin. Eye Res. 44, 36–61 (2015).
doi: 10.1016/j.preteyeres.2014.10.001
Jay, G. D. & Waller, K. A. The biology of lubricin: near frictionless joint motion. Matrix Biol. 39, 17–24 (2014).
doi: 10.1016/j.matbio.2014.08.008
Jay, G. D. Lubricin and surfacing of articular joints. Curr. Opin. Orthop. 15, 355–359 (2004).
doi: 10.1097/01.bco.0000136127.00043.a8
Schmidt, T. A., Sullivan, D. A. & Knop, E. et al. Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface. JAMA Ophthalmol. 131, 766–776 (2013).
doi: 10.1001/jamaophthalmol.2013.2385
Samsom, M. L. et al. Characterization of full-length recombinant human Proteoglycan 4 as an ocular surface boundary lubricant. Exp. Eye Res. 127, 14–19 (2014).
doi: 10.1016/j.exer.2014.06.015
Regmi, S. C. et al. Degradation of proteoglycan 4/lubricin by cathepsin S: potential mechanism for diminished ocular surface lubrication in Sjögren’s syndrome. Exp. Eye Res. 161, 1–9 (2017).
doi: 10.1016/j.exer.2017.05.006
Lambiase, A. et al. A two-week, randomized, double-masked study to evaluate safety and efficacy of lubricin (150 μg/mL) eye drops versus sodium hyaluronate (HA) 0.18% eye drops (Vismed®) in patients with moderate dry eye disease. Ocul. Surf. 15, 77–87 (2017).
doi: 10.1016/j.jtos.2016.08.004
Lee, H. S. et al. Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Invest. Ophthalmol. Vis. Sci. 53, 5632–5640 (2012).
doi: 10.1167/iovs.12-9547
Verstrepen, L. et al. TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme. Cell. Mol. Life Sci. 65, 2964–2978 (2008).
doi: 10.1007/s00018-008-8064-8
Pitenis, A. A. et al. Friction-induced inflammation. Tribology Lett. 66, 81 (2018).
doi: 10.1007/s11249-018-1029-7
Pitenis, A. A. et al. Corneal cell friction: survival, lubricity, tear films, and mucin production over extended duration in vitro studies. Biotribology 11, 77–83 (2017).
doi: 10.1016/j.biotri.2017.04.003
Chao, W. et al. Report of the inaugural meeting of the TFOS i(2) = initiating innovation series: targeting the unmet need for dry eye treatment. Ocul. Surf. 14, 264–316 (2016).
doi: 10.1016/j.jtos.2015.11.003
Baudouin, C. et al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting. Acta Ophthalmol. 96, 111–119 (2018).
doi: 10.1111/aos.13436
Hall, A. The origin and purposes of blinking. Br. J. Ophthalmol. 29, 445–467 (1945).
doi: 10.1136/bjo.29.9.445
Warren, H. S. et al. Mice are not men. Proc. Natl Acad. Sci. USA 112, E345 (2015).
Al-Sharif, A. et al. Lubricin/Proteoglycan 4 binding to CD44 receptor: a mechanism of the suppression of proinflammatory cytokine-induced synoviocyte proliferation by lubricin. Arthritis Rheumatol. 67, 1503–1513 (2015).
doi: 10.1002/art.39087
Iqbal, S. M. et al. Lubricin/Proteoglycan 4 binds to and regulates the activity of toll-like receptors. Vitr. Sci. Rep. 6, 18910 (2016).
doi: 10.1038/srep18910
Waller, K. A., Zhang, L. X. & Jay, G. D. Friction-induced mitochondrial dysregulation contributes to joint deterioration in prg4 knockout mice. Int. J. Mol. Sci. 18, 1252 (2017).
Shaheen, B., Bakir, M. & Jain, S. Corneal nerves in health and disease. Surv. Ophthalmol. 59, 263–285 (2014).
doi: 10.1016/j.survophthal.2013.09.002
Belmonte, C. et al. TFOS DEWS II pain and sensation report. Ocul. Surf. 15, 404–437 (2017).
doi: 10.1016/j.jtos.2017.05.002
Dartt, D. A. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog. Retin. Eye Res. 28, 155–177 (2009).
doi: 10.1016/j.preteyeres.2009.04.003
Morrison, S., Sullivan, D. A., Sullivan, B. D., Sheardown, H. & Schmidt, T. A. Dose-dependent and synergistic effects of proteoglycan 4 on boundary lubrication at a human cornea-polydimethylsiloxane biointerface. Eye Contact Lens 38, 27–35 (2012).
doi: 10.1097/ICL.0b013e31823f7041
Jay, G. D., Tantravahi, U., Britt, D. E., Barrach, H. J. & Cha, C. J. Homology of lubricin and superficial zone protein (SZP): products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25. J. Orthop. Res. 19, 677–687 (2001).
doi: 10.1016/S0736-0266(00)00040-1
Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D. & Reis, B. L. Reliability and validity of the Ocular Surface Disease Index. Arch. Ophthalmol. 118, 615–621 (2000).
doi: 10.1001/archopht.118.5.615
Bunya, V. Y. et al. Development and evaluation of semiautomated quantification of lissamine green staining of the bulbar conjunctiva from digital images. JAMA Ophthalmol. 135, 1078–1085 (2017).
doi: 10.1001/jamaophthalmol.2017.3346

Auteurs

Jeongyun Seo (J)

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.

Woo Y Byun (WY)

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.

Farid Alisafaei (F)

Department of Materials Science and Engineering, University of Pennsylvania, Philadelphia, PA, USA.

Andrei Georgescu (A)

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.

Yoon-Suk Yi (YS)

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.

Mina Massaro-Giordano (M)

Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Penn Dry Eye and Ocular Surface Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Vivek B Shenoy (VB)

Department of Materials Science and Engineering, University of Pennsylvania, Philadelphia, PA, USA.
NSF Science and Technology Center for Engineering Mechanobiology, University of Pennsylvania, Philadelphia, PA, USA.

Vivian Lee (V)

Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Vatinee Y Bunya (VY)

Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Penn Dry Eye and Ocular Surface Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Dongeun Huh (D)

Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA. huhd@seas.upenn.edu.
NSF Science and Technology Center for Engineering Mechanobiology, University of Pennsylvania, Philadelphia, PA, USA. huhd@seas.upenn.edu.
Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. huhd@seas.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH